Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beijing Establishes New Drug Innovation And Production Alliance

This article was originally published in PharmAsia News

Executive Summary

To accelerate the commercialization of pharmaceutical technology and reverse the low market share of Beijing-made drugs, Peking University, Beijing Pharmaceutical Group, Beijing Pharmaceutical Profession Association and 13 other Beijing-based biopharmaceutical institutions have officially formed an industry research alliance. Based on an open system, the enterprises and academic institutions will bring in more organizations to co-develop innovative products within the group. The alliance will focus on setting up a platform in four areas: new drug pilots, guidance for clinical trials, new product R&D and commercialization, and talent cultivation. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072615

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel